Identification of Risk Factors and Symptoms of COVID-19: Analysis of Biomedical Literature and Social Media Data.


Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
02 10 2020
Historique:
received: 20 05 2020
accepted: 13 09 2020
revised: 08 09 2020
pubmed: 17 9 2020
medline: 10 10 2020
entrez: 16 9 2020
Statut: epublish

Résumé

In December 2019, the COVID-19 outbreak started in China and rapidly spread around the world. Lack of a vaccine or optimized intervention raised the importance of characterizing risk factors and symptoms for the early identification and successful treatment of patients with COVID-19. This study aims to investigate and analyze biomedical literature and public social media data to understand the association of risk factors and symptoms with the various outcomes observed in patients with COVID-19. Through semantic analysis, we collected 45 retrospective cohort studies, which evaluated 303 clinical and demographic variables across 13 different outcomes of patients with COVID-19, and 84,140 Twitter posts from 1036 COVID-19-positive users. Machine learning tools to extract biomedical information were introduced to identify mentions of uncommon or novel symptoms in tweets. We then examined and compared two data sets to expand our landscape of risk factors and symptoms related to COVID-19. From the biomedical literature, approximately 90% of clinical and demographic variables showed inconsistent associations with COVID-19 outcomes. Consensus analysis identified 72 risk factors that were specifically associated with individual outcomes. From the social media data, 51 symptoms were characterized and analyzed. By comparing social media data with biomedical literature, we identified 25 novel symptoms that were specifically mentioned in tweets but have been not previously well characterized. Furthermore, there were certain combinations of symptoms that were frequently mentioned together in social media. Identified outcome-specific risk factors, symptoms, and combinations of symptoms may serve as surrogate indicators to identify patients with COVID-19 and predict their clinical outcomes in order to provide appropriate treatments.

Sections du résumé

BACKGROUND
In December 2019, the COVID-19 outbreak started in China and rapidly spread around the world. Lack of a vaccine or optimized intervention raised the importance of characterizing risk factors and symptoms for the early identification and successful treatment of patients with COVID-19.
OBJECTIVE
This study aims to investigate and analyze biomedical literature and public social media data to understand the association of risk factors and symptoms with the various outcomes observed in patients with COVID-19.
METHODS
Through semantic analysis, we collected 45 retrospective cohort studies, which evaluated 303 clinical and demographic variables across 13 different outcomes of patients with COVID-19, and 84,140 Twitter posts from 1036 COVID-19-positive users. Machine learning tools to extract biomedical information were introduced to identify mentions of uncommon or novel symptoms in tweets. We then examined and compared two data sets to expand our landscape of risk factors and symptoms related to COVID-19.
RESULTS
From the biomedical literature, approximately 90% of clinical and demographic variables showed inconsistent associations with COVID-19 outcomes. Consensus analysis identified 72 risk factors that were specifically associated with individual outcomes. From the social media data, 51 symptoms were characterized and analyzed. By comparing social media data with biomedical literature, we identified 25 novel symptoms that were specifically mentioned in tweets but have been not previously well characterized. Furthermore, there were certain combinations of symptoms that were frequently mentioned together in social media.
CONCLUSIONS
Identified outcome-specific risk factors, symptoms, and combinations of symptoms may serve as surrogate indicators to identify patients with COVID-19 and predict their clinical outcomes in order to provide appropriate treatments.

Identifiants

pubmed: 32936770
pii: v22i10e20509
doi: 10.2196/20509
pmc: PMC7537723
doi:

Substances chimiques

Antiviral Agents 0

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

e20509

Informations de copyright

©Jouhyun Jeon, Gaurav Baruah, Sarah Sarabadani, Adam Palanica. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 02.10.2020.

Références

Int J Infect Dis. 2020 May;94:154-155
pubmed: 32179137
PLoS One. 2013 Dec 09;8(12):e83672
pubmed: 24349542
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA. 2018 Jan 23;319(4):388-396
pubmed: 29362800
BJU Int. 2020 Jun;125(6):E7-E14
pubmed: 32249538
Br J Gen Pract. 2015 Jan;65(630):e49-54
pubmed: 25548316
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Nat Med. 2020 Jul;26(7):1037-1040
pubmed: 32393804
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Euro Surveill. 2020 Feb;25(5):
pubmed: 32046816
Anaesthesia. 2020 Mar 30;:
pubmed: 32227594
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Prev Med. 2014 Jun;63:112-5
pubmed: 24513169
BMJ. 2020 Mar 23;368:m1165
pubmed: 32205334

Auteurs

Jouhyun Jeon (J)

Klick Labs, Klick Applied Sciences, Toronto, ON, Canada.

Gaurav Baruah (G)

Klick Labs, Klick Applied Sciences, Toronto, ON, Canada.

Sarah Sarabadani (S)

Klick Labs, Klick Applied Sciences, Toronto, ON, Canada.

Adam Palanica (A)

Klick Labs, Klick Applied Sciences, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH